Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Vaccine Adverse Event Reporting System (VAERS) Publications

Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; The VAERS team. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003. Vaccine 2008; 26(9):1166-72. Epub 2008 Jan 22.
http://www.ncbi.nlm.nih.gov/pubmed/18255204

Begier EM, Burwen DR, Haber P, Ball R; Vaccine Adverse Event Reporting System Working Group. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin Infect Dis. 2004; 38(6):771-9.Epub 2004 Feb 26.
http://www.ncbi.nlm.nih.gov/pubmed/14999618

Begier EM, Langford CA, Sneller MC, Wise RP, Ball R; VAERS Working Group. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis. J Rheumatol. 2004; 31(11):2181-8.
http://www.ncbi.nlm.nih.gov/pubmed/15517631

Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS, VAERS Working Group. Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years’ data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics 2000; 106(4):E51.
http://www.ncbi.nlm.nih.gov/pubmed/11015546

Broder KR, Martin DB, Vellozzi C. In the heat of a signal: Responding to a vaccine safety signal for febrile seizures after 2010–11 influenza vaccine in young children, United States. Vaccine 2012; 30(11):2032-2034.
http://www.ncbi.nlm.nih.gov/pubmed/22361305

Centers for Disease Control and Prevention (CDC). Syncope after vaccination--United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep. 2008 May 2; 57(17):457-60.
http://www.ncbi.nlm.nih.gov/pubmed/18451756

Centers for Disease Control and Prevention (CDC). Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007. MMWR Morb Mortal Wkly Rep. 2007 Mar 16; 56(10):218-22.
http://www.ncbi.nlm.nih.gov/pubmed/17363890

Centers for Disease Control and Prevention (CDC). Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006. MMWR Morb Mortal Wkly Rep. 2006 Apr 7; 55(13):364-6.
http://www.ncbi.nlm.nih.gov/pubmed/16601664

Centers for Disease Control and Prevention (CDC). Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005–September 2006. MMWR Morb Mortal Wkly Rep. 2006 Oct 20; 55(41):1120-4.
http://www.ncbi.nlm.nih.gov/pubmed/17060898

Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. Journal of Infectious Diseases 2008; 197 Suppl 2:S170-7.
http://www.ncbi.nlm.nih.gov/pubmed/18419393

DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; V.A.E.R.S. Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 2006; 24(6):703-7. Epub 2005 Aug 9.
http://www.ncbi.nlm.nih.gov/pubmed/16154669

Top of Page

Haber P, Iskander J, Walton K, Campbell SR, and Kohl KS.  Internet-Based Reporting to the Vaccine Adverse Event Reporting System: A More Timely and Complete Way for Providers to Support Vaccine Safety. Pediatrics 2011; 127 Suppl 1: S39-44. Epub 2011 Apr 18.
http://www.ncbi.nlm.nih.gov/pubmed/21502243

Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf. 2009; 32(4):309-23. doi: 10.2165/00002018-200932040-00005.
http://www.ncbi.nlm.nih.gov/pubmed/19388722

Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar U. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008; 121(6):1206-12.
http://www.ncbi.nlm.nih.gov/pubmed/18519491

Haber P, Slade B, Iskander J. (Letter to the Editor). Guillain-Barré Syndrome (GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System (VAERS) in 2004. Vaccine. 2007; 25(48):8101. Epub 2007 Oct 1.
http://www.ncbi.nlm.nih.gov/pubmed/17933441

Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT. Guillain-Barré syndrome following influenza vaccination. JAMA. 2004; 292(20):2478-81.
http://www.ncbi.nlm.nih.gov/pubmed/15562126

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone? Pediatrics 2004; 113(4):e353-9.
http://www.ncbi.nlm.nih.gov/pubmed/15060267

Hua W, Izurieta HS, Slade B, Belay ED, Haber P, Tiernan R, Woo EJ, Iskander J, Braun MM, Ball R.
Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007. Pediatr Infect Dis J. 2009; 28(11):943-7.
http://www.ncbi.nlm.nih.gov/pubmed/19755926

Huang WT, Chang S, Miller ER, Woo EJ, Hoffmaster AR, Gee JE, Clark TA, Iskander JK, Ball R, Broder KR. Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008. Pharmacoepidemiol and Drug Saf. 2010; 19(3):306-10.
http://www.ncbi.nlm.nih.gov/pubmed/20084617

Iskander J, Pool V, Zhou W, English-Bullard R; The VAERS Team. Data mining in the US using the Vaccine Adverse Event Reporting System. Drug Saf. 2006; 29(5):375-84. http://www.ncbi.nlm.nih.gov/pubmed/16689554

Iskander JK, Miller ER, Chen RT. The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety. Pediatr Ann. 2004; 33(9):599-606.
http://www.ncbi.nlm.nih.gov/pubmed/15462575

Izurieta HS, Haber P, Wise RP, Iskander J, Pratt D, Mink C, Chang S, Braun MM, Ball R. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA. 2005; 294(21):2720-5. Erratum in: JAMA. 2005 Dec 28; 294(24):3092.
http://www.ncbi.nlm.nih.gov/pubmed/16333007

Lathrop SL, Ball R, Haber P, Mootrey GT, Braun MM, Shadomy SV, Ellenberg SS, Chen RT, Hayes EB. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine. 2002; 20(11-12):1603-8.
http://www.ncbi.nlm.nih.gov/pubmed/11858868

Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D.  Febrile seizures after 2010–2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting system. Vaccine 2012; 30(11):2020-3.
http://www.ncbi.nlm.nih.gov/pubmed/22361303

Lindsey NP, Staples JE, Jones JF, Sejvar JJ, Griggs A, Iskander J, Miller ER, Fischer M. Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009. Vaccine. 2010; 29(1):58-64. Epub 2010 Nov 4.
http://www.ncbi.nlm.nih.gov/pubmed/20970488

Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB. Adverse event reports following yellow fever vaccination. Vaccine. 2008; 26(48):6077-82. Epub 2008 Sep 20.
http://www.ncbi.nlm.nih.gov/pubmed/18809449

Lloyd JC, Haber P, Mootrey GT, Braun MM, Rhodes PH, Chen RT; VAERS Working Group. Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine. 2003; 21(25-26):3746-50.
http://www.ncbi.nlm.nih.gov/pubmed/12922107

Top of Page

McMahon AW, Iskander JK, Haber P, Braun MM, Ball R. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine. 2008; 26(3):427-9. Epub 2007 Nov 29.
http://www.ncbi.nlm.nih.gov/pubmed/18093701

McMahon AW, Iskander J, Haber P, Chang S, Woo EJ, Braun MM, Ball R. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.  Pediatrics 2005; 115(2):453-60.
http://www.ncbi.nlm.nih.gov/pubmed/15687455

McNeil MM, Broder KR, Vellozzi C, DeStefano F. Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data. Clinical Infectious Diseases. 2010; 51(7):871-2; author reply 872-3.
http://www.ncbi.nlm.nih.gov/pubmed/20809843

Miller ER, Woo EJ. Time to prevent injuries from postimmunization syncope. Nursing. 2006; 36(12 Pt.1):20.
http://www.ncbi.nlm.nih.gov/pubmed/17135895

Moro PL, Arana J, Cano M, Menschik D, Yue Lewis P, Haber P, Martin D, Broder K.Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010–31 December 2010.Clinical Infectious Diseases 2012; 54(11):1608-14. Epub 2012 Mar 22.
http://www.ncbi.nlm.nih.gov/pubmed/22441652

Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, Barash F, Arana J, Brantley MD, Ding H, Singleton JA, Walton K, Haber P, Lewis P, Yue X, Destefano F, Vellozzi C. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. American Journal of Obstetrics and Gynecology 2011; 205(5):473.e1-9. Epub 2011 Jun 21.
http://www.ncbi.nlm.nih.gov/pubmed/21861964

Moro PL, Yue X, Lewis P, Haber P, Broder K. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.Vaccine. 2011; 29(50):9404-8. Epub 2011 Sep 13.
http://www.ncbi.nlm.nih.gov/pubmed/21920404

Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, Guh A, Haber P, Destefano F, Vellozzi C. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. American Journal of Obstetrics and Gynecology 2011 Feb; 204(2):146.e1-7. Epub 2010 Oct 20.
http://www.ncbi.nlm.nih.gov/pubmed/20965490

Muhammad RD, Haber P, Broder KR, Leroy Z, Ball R, Braun MM, Davis RL, McMahon AW. Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System. The Pediatric Infectious Disease  Journal. 2010 Oct 29. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/21042229

Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM; VAERS Working Group. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. Vaccine. 2009; 27(2):290-7. Epub 2008 Nov 6.
http://www.ncbi.nlm.nih.gov/pubmed/18992783

Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception and rotavirus vaccination: a review of the available evidence. Expert Review of Vaccines. 2009; 8(11):1555-64.
http://www.ncbi.nlm.nih.gov/pubmed/19863248

Slade BA, Gee J, Broder KR, Vellozzi C. Comment on the contribution by Souayah et al., "Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009". Vaccine. 2011; 29(5):865-6. Epub 2010 Nov 25.
http://www.ncbi.nlm.nih.gov/pubmed/21111783

Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009; 302(7):750-7.
http://www.ncbi.nlm.nih.gov/pubmed/19690307

Takahashi H, Pool V, Tsai TF, Chen RT. Adverse events after Japanese Encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. Vaccine 2000: 18(26):2963-9.
http://www.ncbi.nlm.nih.gov/pubmed/10825597

Top of Page

Varricchio F, Reed J; VAERS Working Group. Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS). Southern Medical Journal. 2006; 99(5):486-9.
http://www.ncbi.nlm.nih.gov/pubmed/16711311

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. The Pediatric Infectious Disease Journal. 2004; 23(4):287-94.
http://www.ncbi.nlm.nih.gov/pubmed/15071280

Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F.  Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010; 28(45):7248-55. Epub 2010 Sep 16.
http://www.ncbi.nlm.nih.gov/pubmed/20850534

Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine. 2009 Mar 26; 27(15):2114-20. Epub 2009 Feb 6.
http://www.ncbi.nlm.nih.gov/pubmed/19356614

Vellozzi C, Mitchell T, Miller E, Casey CG, Eidex RB, Hayes EB. Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996-2004. The American  Journal of Tropical Medicine and Hygiene. 2006; 75(2):333-6.
http://www.ncbi.nlm.nih.gov/pubmed/16896144

Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT; Vaccine Adverse Event Reporting System Team. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. American Journal of Epidemiology. 2001; 154(11):1006-12.
http://www.ncbi.nlm.nih.gov/pubmed/11724716

Wise RP, Iskander J, Pratt RD, Campbell S, Ball R, Pless RP, Braun MM. Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA. 2004; 292(14):1702-10.
http://www.ncbi.nlm.nih.gov/pubmed/15479935

Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR. Post licensure safety surveillance for varicella vaccine. JAMA 2000; 284:1271-9.
http://www.ncbi.nlm.nih.gov/pubmed/10979114

Wong C, Krashin J, Rue-Cover A, Saraiya M, Unger E, Calugar A, Markowitz L. Invasive and in situ cervical cancer reported to the vaccine adverse event reporting system (VAERS). Journal of Womens Health (Larchmt). 2010; 19(3):365-70.
http://www.ncbi.nlm.nih.gov/pubmed/20141382

Woo EJ, Wise RP, Menschik D, Shadomy SV, Iskander J, Beeler J, Varricchio F, Ball R. Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008. Vaccine. 2011; 29(6):1319-23. Epub 2010 Nov 30.
http://www.ncbi.nlm.nih.gov/pubmed/21126606

Woo EJ, Ball R, Landa R, Zimmerman AW, Braun MM; VAERS Working Group. Developmental regression and autism reported to the Vaccine Adverse Event Reporting System. Autism. 2007; 11(4):301-10.
http://www.ncbi.nih.gov/pubmed/17656395

Woo EJ, Miller NB, Ball R; VAERS Working Group. Adverse events after hepatitis A B combination vaccine. Vaccine. 2006; 24(14):2685-91. Epub 2005 Nov 9.
http://www.ncbi.nih.gov/pubmed/16310295

Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, Tokars JI, Vellozzi C, Broder KR. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol. 2012 Jul; 207(1):59.e1-7. Epub 2012 May 14.
http://www.ncbi.nlm.nih.gov/pubmed/22727350

Zanardi LR, Haber P, Mootrey GT, Niu MT, Wharton M. Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system. Pediatrics. 2001; 107(6):E97.
http://www.ncbi.nlm.nih.gov/pubmed/11389295

Zhou W, Pool V, DeStefano F, Iskander JK, Haber P, Chen RT; VAERS Working Group. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Pharmacoepidemiol Drug Saf. 2004; 13(8):505-10.
http://www.ncbi.nlm.nih.gov/pubmed/15317028

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. MMWR Surveill Summ. 2003 Jan 24; 52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14; 52(06):113.
http://www.ncbi.nlm.nih.gov/pubmed/12825543

Top of Page

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #